Inhibition of influenza virus production in virus-infected mice by RNA interference
- 8 June 2004
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 101 (23) , 8676-8681
- https://doi.org/10.1073/pnas.0402486101
Abstract
Influenza A virus infection is a major source of morbidity and mortality worldwide. Because the effectiveness of existing vaccines and antiviral drugs is limited, development of new treatment modalities is needed. Here, we show that short interfering RNAs (siRNAs) specific for conserved regions of influenza virus genes can prevent and treat influenza virus infection in mice. Virus production in lungs of infected mice is reduced by siRNAs given either before or after initiating virus infection, by using slow i.v. administration of small volumes containing siRNAs in complexes with a polycation carrier. Similar effects also are observed when mice are given DNA vectors i.v. or intranasally, from which siRNA precursors can be transcribed. Development of delivery systems that may be compatible with human use demonstrates the potential utility of siRNAs for prophylaxis and therapy of influenza virus infections in humans.Keywords
This publication has 42 references indexed in Scilit:
- Inhibition of Human Immunodeficiency Virus Type 1 Replication in Primary Macrophages by Using Tat- or CCR5-Specific Small Interfering RNAs Expressed from a Lentivirus VectorJournal of Virology, 2003
- Activation of the interferon system by short-interfering RNAsNature Cell Biology, 2003
- Inhibition of hepatitis B virus in mice by RNA interferenceNature Biotechnology, 2003
- A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interferenceNature Genetics, 2003
- RNA interference in adult miceNature, 2002
- A System for Stable Expression of Short Interfering RNAs in Mammalian CellsScience, 2002
- Development of Biomaterials for Gene TherapyMolecular Therapy, 2000
- Rapid crossing of the pulmonary endothelial barrier by polyethylenimine/DNA complexesGene Therapy, 2000
- Comparison between cationic polymers and lipids in mediating systemic gene delivery to the lungsGene Therapy, 1999
- Polyethylenimine-based intravenous delivery of transgenes to mouse lungGene Therapy, 1998